Overview

Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
This open label single blind study will determine the safety of albuterol sulfate dry powder in a novel inhaler by observing for the potential occurrence of reflex bronchial constriction after inhalation of increasing doses of the compound.
Phase:
Phase 1
Details
Lead Sponsor:
Respirics Inc.
Treatments:
Albuterol